Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a γ320Asp deletion at the Ca2+ binding site

Thrombosis and Haemostasis

Volumn 98, Issue 2, 2007, Pages 467-469

  Brennan, Stephen O ^a   Davis, Ryan L ^b   Mosesson, Michael W ^b   Hernandez, Irene ^b   Lowen, Robin ^a   Alexander, Saramma J ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c Medical Oncology and Hematology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIGEN; ASPARTIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CALCIUM ION; EDETIC ACID; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; PROTHROMBIN; WARFARIN;

ADULT; AORTA THROMBOSIS; ARTICLE; BINDING SITE; BLEEDING DISORDER; CASE REPORT; DYSFIBRINOGENEMIA; ELECTROSPRAY MASS SPECTROMETRY; EMBOLECTOMY; ERYTHROCYTE TRANSFUSION; FAMILY HISTORY; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; ISOELECTRIC FOCUSING; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; THROMBIN TIME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AFIBRINOGENEMIA; BINDING SITES; CALCIUM; FAMILY HEALTH; FEMALE; FIBRINOGENS, ABNORMAL; FRAMESHIFT MUTATION; HUMANS;

EID: 34547897404     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-01-0012     Document Type: Article

References (20)

1. Henschen AH, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Blood Coagulation, Vol 13. Zwaal RFA, Heraker HC, eds. Amsterdam: Elsevier Science Publishers BV 1986: 171-241.
2. Doolittle RF. The molecular biology of fibrin. In: The Molecular Basis of Blood Diseases. Philadelphia WB Saunders Co. 1994: 701-726.
3. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 1997; 389: 455-462.
4. Yee VC, Pratt KP, Cote HCF, et al. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen. Structure 1997; 5: 125-138.
5. Yang Z, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci USA 2000; 97: 14156-14161.
6. Mosesson MW, Siebenlist KR, Hainfeld JF, et al. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. J Struct Biol 1995; 115: 88-101.
7. Huang S, Mulvihill ER, Farrell DH, et al. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in assembly. J Biol Chem 1993; 268: 8919-8926.
8. Huang S, Cao Z, Chung DW, et al. The role of αγ and βγcomplexes in the assembly of human fibrinogen. J Biol Chem 1996; 271: 27942-27947.
9. Maghzal GJ, Brennan SO, Homer VM, et al. The molecular mechanisms of congenital hypofibrinogenaemia. Cell Mol Life Sci 2004; 61: 1427-1438.
10. Hanss M, Biot FA. A database for human fibrinogen variants. Ann NY Acad Sci 2001; 86: 154-163; Available online at http://www.geht.org/ databaseang/fibrinogen.
11. Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (Aγ20Val→Asp). J Clin Invest 1995; 96: 2854-2858.
12. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997; 78: 1055-1058.
13. Brennan SO, Wyatt J, Medicina D, et al. Fibrinogen Brescia; hepatic endoplasmic reticulum storage and hypofibrinogenaemia because of a γ284 Gly→Arg mutation. Am J Pathol 2000; 157: 189-196.
14. Fellowes AP, Brennan SO, Ridgway HJ, et al. Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (γ280Tyr→Cys) - a new variant with defective polymerization. Br J of Haematol 1998; 101: 24-31.
15. Mullin JL, Brennan SO, Ganly PS, et al. Fibrinogen Hillsborough: a novel γ309Gly→Asp dysfibrinogen with impaired clotting. Blood 2002; 99: 3597-3610.
16. Koopman J, Haverkate F, Briet E, et al. Congenitally abnormal fibrinogen (Vlissingen) with a 6-base pair deletion in the γ gene, causing defective calcium binding and impaired fibrin polymerization J Biol Chem 1991; 266: 13456-13461.
17. Terasawa F, Hogan KA, Kani S, et al. Fibrinogen Otsu I; a γAsn319, γAsp 320 deletion dysfibrinogen identified in a pregnant woman. Thromb Haemost 2003; 90: 757-758.
18. Kelley KA,Gourkun OV, Lounes KC, et al. Recombinant fibrinogen Vlissingen/Frankfurt IV the deletion of residues 319 and 320 from the ? chain alters calcium binding, fibrin polymerization, cross-linking and platelet aggregation. J Biol Chem 2000; 275: 17778-17785.
19. Kani S, Terasawa F. Lord ST. et al In vitro expression demonstrates impaired secretion of the γAsn319, Asp320 deletion variant fibrinogen. Thromb Haemost 2005; 94: 53-59.
20. Haverkate F, Samama M. Familial dysfibrinogenaemia and thrombophilia: Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 1995; 73: 151-161.